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Ca2+-Calmodulln Dependent Inactivation of TRPM2
by

Oies Hussein

The interaction o f Ca2+-calmodulin is known to promote Ca2+-dependent negative
feedback on the activity of various Ca permeable channels through Ca -dependent
inactivation. Our laboratory has previously observed a progressive, time-dependent
inactivation o f TRPM2 (melastatin-related transient receptor potential channel 2). Currents
were evoked from HEK 293T cells stably expressing TRPM2, through-the intracellular
application of ADPR. TRPM2-mediated currents developed rapidly, reaching a peak and
decaying to a steady state in the continued presence o f extracellular Ca . Full recovery of
TRPM2 channels from inactivation was dependent on ADPR concentration. Inactivation
was reduced at more depolarized membrane potentials, consistent with a reduced driving
force and influx of Ca2+. The extent o f inactivation was dependent on extra- and
intracellular Ca2+. Exogenous application o f calmodulin results in a slower recovery of
TRPM2 channels, in addition to increased inactivation. In conclusion, I have shown that
TRPM2 channels are susceptible to Ca2+-dependent inactivation involving calmodulin.
ry I

f\ i

A I

Keywords: TRPM2, ADPR, Calmodulin, Ca2+-dependent inactivation, Ca2+-Calmodulin

iii

Acknowledgements:
I would like to thank Dr. John MacDonald for the opportunity I had as a graduate
student in your lab. The opportunity in your lab permitted me to continue to mature as a
student and person. I also appreciate your guidance and advice throughout my time spent in
your lab. In addition to Dr. John MacDonald’s supervision, Dr. Mike Jackson’s help and
understanding as a co-supervisor helped me cope with research. I would like to thank Dr.
Mike Jackson for helping me leam and excel in research under his supervision.
I appreciate the support I had from all my lab mates throughout the bad and good
days in the lab. I would like to also thank Lidia Brandes and Natalie Lavine for preparing
cell cultures, cell lines and mutations which were used in my research.
I would like to thank all my friends and family for their continued support
throughout my life. Being raised in a big family I have to thank my parents and all my
siblings, nieces, nephews, and brother-in-laws for cheering me up during difficult times in
my life. I must thank Kim Beaucage for helping me cope with my time away from home
and also for always being there for me.

iv

Table of Contents
Certificate o f Examination...ii
Abstract...iii
Acknowledgements.. .iv
Table o f Contents...V
List o f Figures., .vii
Abbreviations.. .viii
Section 1 - Introduction

1.1
1.2
1.3
1.4
1.5

1.6
1.7

1.8

Ca2+ dysrégulation...2
TRPM2...3
Topology of TRPM2.. .4
Pharmacological properties of TRPM2...7
Ca2+and TRPM2 function... 13
Calmodulin... 14
Ca2+-dependent inactivation... 16
Hypothesis and objectives...19

Section 2 - Methods and Materials
2.1
2.2
2.3
2.4
2.5

~—

Whole-cell recordings from HEK 293 cells...21
Single-point mutation protocol for calmodulin mutants...23
Lipofectamine 2000 transfection for HEK 293 cells...25
Chemicals, drugs, and peptides...26
Data analysis/stats...26

Section 3 - Results
3.1
3.2
3.3
3.4
3.5
3.6
3.7

Time-dependent inactivation o f TRPM2 channels in HEK 293 cells...28
Inactivation as a Ca2+-dependent process...34
Extracellular as a Ca2+-dependent process...34
Dependence o f inactivation on intracellular Ca2+...37
Administration o f calmodulin...39
Calmodulin inhibitors...40
Effect o f CaM mutants on inactivation...45

Section 4 - Discussion
4.1
4.2
4.3
4.4
4.5
4.6

Summary o f key findings...48
Progressive time-dependent inactivation of TRPM2.. .48
ADPR dose-dependent inactivation o f TRPM2...49
Extracellular [Ca2+]-dependent inactivation...53
Intracellular [Ca24]-dependent inactivation... 56
Calmodulin as the Ca2+ sensor in L-type Ca2+ channel inactivation...58
V

4.7
4.8
4.9
4.10
4.11
4.12

Calmodulin as the Ca2+ sensor in TRPM2 regulation...59
Calmodulin confers an increase in inactivation... 62
CaM inhibitors and m utagenesis...63
Physiological and pathophysiological roles o f TRPM2...66
Future directions...69
Significance of this work...70

Section 5 - References...71
Curriculum V itae...84

VI

List of Figures:
Figure 1: Transmembrane topology o f TRPM 2...6
Figure 2: Intracellular ADPR production. ..11
Figure 3: Schematic of TRPM2 illustrating Ca2+-CaM dependent regulation... 18
Figure 4: Schematic o f whole cell recording in HEK 293 cells stably expressing
TRPM2...22
Figure 5: Calmodulin m utants...24
Figure 6 : Time-dependent inactivation in HEK cells stably expressing TRPM2...30
Figure 7: Time course o f recovery with varying times of Ca -free solution
administration...31
Figure 8: Recovery from inactivation with varying ADPR concentration...32
Figure 9 : Time course o f recovery from inactivation is dependent on the concentration of
ADPR...33
n

Figure 10: Inactivation of TRPM2 is dependent on Ca

I

influx determined by varying the

holding voltage during whole cell recording...35
Figure 11: Extracellular [Ca2+]-dependentinactivation...36
Figure 12: Inactivation o f TRPM2 is dependent on intracellular [Ca2+]...38
Figure 13: Representative recordings used to determine the extent of peak recovery
following inactivation...41
Figure 14: Inactivation o f TRPM2 is dependent on calmodulin...42
Figure 15: Determining the effect o f calmodulin inhibitors on inactivation...43
Figure 16: Time course of recovery from inactivation in the presence of calmodulin...44
Figure 17: Calmodulin mutants have no effect on TRPM2 inactivation...46
vii

Abbreviations and Acronyms:
[Ca2+]: Calcium concentration
[Ca2+]i: Free-intracellular calcium concentration
2-APB: 2-aminoethoxydiphenyl borate
ACA: Anthranilic acid
AD: Alzheimer’s disease
ADPR: Adenosine diphosphate ribose
ALS: Amyotrophic lateral sclerosis
AMP: Adenosine monophosphate
BAPTA: 2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
BD: Bipolar disorder
cADPR: cyclic adenosine diphosphate ribose
CaM: Calmodulin
CCD: Coiled-coiled domain
EC 50: H alf maximal effective concentration
ECS: Extracellular solution
EGTA: Ethylene glycol tetraacetic acid
Erev: Reversal potential
FFA: Flufenamic acid
Ga3+: Gadolinium
GFP: Green fluorescent protein
H 2O2: Hydrogen peroxide
HEK 293: Human embryonic kidney cell line
ICS: Intracellular solution
Iss/Ip: Steady state/peak ratio (estimate of the extent of inactivation)
La3+: Lanthanum
MEM: Modified Eagle Medium
mPTP: mitochondrial transition pore opening
NAD+: Nicatinamide adenine dinucleatide
NMDA receptor: N-Methyl-D-aspartic acid receptor
NUDIX: Nucleoside diphosphate coupled to a varying moiety X (NUDT9-H)
O Ca2+: Ca2+-free extracellular solution
P2/P1: 2nd peak/lst peak, ratio was utilized as an inactivation index
PARG: polyADPR-glycohydrolase
PARP: polyADPR-polymerase
PD: Parkinson’s disease
ROS/RNS: Reactive oxygen/nitrogen species
t: time constant of recovery measured by tau value of exponential decay fit
TRP: Transient receptor potential
TRPM2: Melastatin-related transient receptor potential channel 2
VGCC: Voltage-gated calcium channels
WP-ALS: Western Pacific amyotrophic lateral sclerosis

Section 1
Introduction

l

1 .1 Ca2+dysregulation
The role o f Ca2+ ions in cell signalling has been demonstrated in many cellular
processes including transmitter release, cell proliferation and cell death (Jiang et al., 2010;
Nilius et al., 2007). The gradient maintained in cells between the free intracellular [Ca2+]
([Ca2+]i) (approximately 100 nM) and extracellular [Ca2+] (in the mM ranges) is important
in cell signalling (Clapham, 2007). Ca2+ channels represent a diverse family of channels
with broad physiological and pathophysiological functions. Voltage-gated calcium
channels (VGCC) are an example o f Ca

channels that regulate fast Ca

signalling and

which cause dramatic changes in intracellular [Ca2+] (Clapham, 2007). An important
physiological role o f Ca2+ channels is to maintain proper [Ca2+] homeostasis (GordonShaag et al., 2008). Drastic changes to the [Ca2+]i could result in Ca2+ dysregulation.
Furthermore, Ca2+ dysregulation due to the inability to buffer excessive levels o f [Ca2+]i
may result in subsequent cell death. Thus maintaining Ca2+ homeostasis is one o f many
A i

essential mechanisms amongst Ca

channels.

A diverse superfamily o f Ca2+ channels referred to as transient receptor potential
(TRP) channels were identified due to their homology to TRP proteins, discovered in 1977
in Drosophila phototransduction mutants (Minke, 1977). Many TRP channels demonstrate
some permeability to Ca2+ but to varying degrees (Clapham et al., 2001; Clapham, 2002;
Montell, 2001; Zhu and Bimbaumer, 1998). TRPM (melastatin-related transient receptor
potential) subfamily have been an emerging group of channels that exhibit wide range of
ir
physiological and pathological functions (Nilius et al., 2005). A growing body of research
has focused on TRPM2 (melastatin-related transient receptor potential channel 2) due to its
potential role in cell death (Nilius et al., 2005). TRPM2 channels are non-selective cation
2

channels that exhibit a strong requirement o f intracellular Ca

I

for activation. Indicating

that the influx o f Ca2+ represents an important determinant of their physiological role
(Gordon-Shaag et al., 2008). Consequently the dysrégulation o f [Ca2+]i by TRPM2
channels may lead to cell death and disease. There are various diseases associated with
uncontrolled levels o f [Ca2+]i including; Alzheimer’s disease (AD), Parkinson’s disease
(PD), Western Pacific amyotrophic lateral sclerosis (WP-ALS), ischemic stroke and bipolar
disorder (Xu et al., 2006; Xu et al., 2009). Therefore the role of TRPM2 with respect to

[Ca2+]i regulation and cell death makes it an attractive therapeutic target for diseases.

1.2TRPM2:
There are 28 mammalian homologues of TRP, which fall into six groups: TRPC
(canonical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin), TRPP (polycystin)
and TRPML (mucolipin)(Jiang et al., 2010). TRPM2, (melastatin-related transient receptor
potential channel 2) is a member o f the TRP family of non-selective cation channels. In
addition to permeability to Na+ and K+, TRPM2 has demonstrated substantial permeability
to Ca2+ (Hara et al., 2002; McHugh et al., 2003; Perraud et al., 2001; Sano et al., 2001).
This channel is activated in response to oxidative stress (reactive oxygen species) thus
acting as a redox sensor (Naziroglu and Luckhoff, 2008a; Naziroglu and Luckhoff, 2008b).
Although TRPM2 is expressed predominately in the brain, it has been detected in many
other tissues such as: bone marrow, spleen, heart, leukocytes, lung and liver (Du et al.,
2009; Nagamine et al., 1998; Perraud et al., 2001).

3
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1.3 Topology of TRPM2
TRPM2, (previously named TRPC7 and LTRPC-2) is a tetrameric assembly of four
subunits which form a pore that is permeable to K+, Na+ and Ca2+ ions. Each o f the four
subunits contains 6 membrane-spanning domains, with long cytoplasmic N- and Cterminal tails. There is also a pore-forming re-entrant loop located between transmembrane
domains 5 and 6 (Fig. 1). There is a region in the N-terminus o f approximately 700 amino
acids which is highly conserved among all TRPM family members (Perraud et al., 2003).
This region is referred to as the TRPM homology domain, and evidence hints that this
region regulates assembly and/or surface expression o f TRPM2. The C-terminus contains
a TRP domain which consists of highly conserved residues amongst TRP family members
and a coiled-coiled domain (CCD) consistent in all TRPM channelsTThe TRP domain
consists o f a 23- to 25-amino acid region that includes two distinct TRP boxes; TRP box 1
and TRP box 2 (Montell, 2005). TRPM subfamily contains a less conserved TRP box 1
region o f 5-amino acid (Trp-Lys-Phe-Gln-Arg), in comparison to TRPC which has a fully
conserved region amongst the subfamily (Clapham, 2003; Montell, 2005). TRP box 2
within the TRP domain of TRPM2 is a proline-rich m otif (Montell, 2005). Other than being
conserved amongst TRPM subfamily, the role of the TRP domain is not fully understood.
Studies have predicted the presence of two CCD, one in the C-terminus and the other in the
N-terminus (Mei and Jiang, 2009). The CCD in the C-terminus has been shown to be
involved with TRPM2 subunit-subunit interactions and formation of the tetrameric channel
(Jiang et al., 2010; Mei et al., 2006; Mei and Jiang, 2009). Mei et al. (2009) determined that
the CCD in the N-terminus was not involved with subunit interactions or formation of
functional TRPM2 channels. Their studies instead indicated that the CCD in the N4

5
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terminus o f TRPM2 was important in TRPM2 protein expression (Mei and Jiang, 2009).
Another domain located in the C-terminus, the NUDT9-H domain is a unique sequence
found in TRPM2. This region contributes to the gating o f TRPM2 by ADPR (adenosine
diphosphate ribose) (McHugh et al., 2003; Perraud et al., 2001).
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Figure 1: Transm em brane topology of TRPM 2. TRPM2 is composed of 6 membranespanning domains with a pore-forming re-entrant loop locates between transmembrane
domains 5 and 6. The long cytoplasmic C terminal tail is the site of the NUDIX (nucleoside
diphosphate coupled to a varying moiety X) motif which is responsible for binding of
ADPR. Localized in the N terminal tail of the channel is the CaM binding motif which is
the site of Ca2+-CaM interaction.
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1.4 Pharmacological properties of TRPM2
Ligand for TRPM2:
The binding o f ADPR to an enzyme m otif (NUDT9-H), localized within the
intracellular C-terminal tail o f the channel, contributes to the gating o f TRPM2; effectively
,

V

ADPR is an intracellular ligand (Perraud et al., 2001; Perraud et al., 2003). The 270 amino
acid C-terminal NUDT9-H domain is homologous to the mitochondrial NUDT9 enzyme
(Perraud et al., 2003). This NUDIX domain is found in enzymes which hydrolyze
nucleoside diphosphates (Bessman et al., 1996). The NUDT9-H domain in TRPM2
hydrolyze

ADPR to AMP

and ribose-5-phosphate,

thus being an ADP-ribose

pyrophosphatase (Perraud et al., 2001). To determine the role o f ADPR in gating and
regulation o f TRPM2, ADPR was administered within the intracellulaFsolution in whole
cell recordings. Human embryonic kidney cell line (HEK 293) with a Flag-tagged TRPM2
construct was utilized to determine the role o f ADPR (Perraud et al., 2001). Concentrationresponse curve analysis, performed by Perraud et al., (2001), support an ADPR-dependent
gating o f TRPM2 through the interaction o f ADPR with NUDT9-H domain (Perraud et al.,
2001). In addition to the lack o f enzymatic activity o f the NUDT9-H domain, the direct
interaction o f ADPR with NUDT9-H supports channel opening due to conformational
changes (Perraud et al., 2001; Perraud et al., 2003). In the presence o f 100 pM ADPR,
recordings from HEK cells stably expressing TRPM2, demonstrated large inward and
outward currents which reversed at 0 mV (indicating that there is no net movement o f ions
at 0 mV) (Perraud et al., 2001). The reversal at 0 mV suggests that TRPM2 is a nonselective cation channel. Furthermore, the voltage-relation for TRPM2 is linear suggesting
channel gating is independent o f voltage.
7

Other Activators:
The binding o f intracellular NAD+ (nicatinamide adenine dinucleotide) might also
directly gate TRPM2. Unlike ADPR which can regulate TRPM2 at micromolar ranges
(EC 50 o f 10-90pM) NAD+ requires millimolar concentrations (EC 50 of 1-1.8 mM) (Hara et
al., 2002; Naziroglu and Luckhoff, 2008a; Sano et al., 2001; Sumoza-Toledo and Penner,
2010). To determine whether NAD+ directly binds and activates TRPM2, binding assays
were performed (Grubisha et al., 2006). In contrast to assays for ADPR, NAD+ displayed
negligible binding to the cytoplasmic domain (NUDT9-H domain) o f TRPM2 (Grubisha et
al., 2006). Other groups indicated that direct TRPM2 activation by NAD+ is unlikely. They
suggested that the NAD+-activated currents are likely due to ADPR contamination (Beck et
al., 2006; Grubisha et al., 2006; Kolisek et al., 2005). Another problem with evidence that
NAD+ plays a direct role with gating TRPM2 arises since ADPR is a direct degradation
product o f NAD+ (Scharenberg, 2005). Several other NAD metabolites can activate
TRPM2 including; 2-O-acetyl-ADPR, cyclic ADPR (cADPR) and nicotinic acid-adenine
dinucleotide phosphate (Fliegert et al., 2007; Grubisha et al., 2006). There seems to be
synergistic effects of the accumulation o f ADPR with any of the other activators (Beck et
al., 2006). TRPM2 is a temperature sensitive channel that can be activated by an increase in
temperature (Togashi et al., 2006). Whole-cell recordings were performed with the addition
o f either NAD or ADPR. Currents from HEK-293 cells exposed to warm temperatures
(>35C) resulted in a robust activation of the currents. To further demonstrate the effects of
temperature on TRPM2, Togashi et al., (2006) administered cADPR to the intracellular
solution (ICS) (Togashi et al., 2006). Although cADPR does not activate TRPM2 at room

8

temperature, the co-administration of cADPR and heat (35C) resulted in robust activation
o f TRPM2 currents (Togashietal., 2006).
Another known activator of TRPM2 is oxidative stress. Oxidative stress results in
an increase in reactive oxygen species/reactive nitrogen species (ROS/RNS), including
hydrogen peroxide (H 2O 2) (Naziroglu and Luckhoff, 2008b) which activates TRPM2.
However, the mechanism in which H 2O2 activates the channel is debated.
Recent literature from various groups suggests H 2O2 activates the channel through
an ADPR-dependent process. Production o f H 2O2 in the cytosol from oxidative stress
causes an accumulation of ADPR (Hara et al., 2002; Kuhn et al., 2005; Perraud et al.,
2005). The production of free ADPR occurs in the mitochondria and nucleus (Perraud et
al., 2005). Experiments with mutations o f the NUDT9-H domain significantly reduced
activation by H 2O 2 and ADPR (Perraud et al., 2005). This suggested the importance of the
binding o f ADPR to the activation of TRPM2 by H 2O2. The production of ADPR following
DNA damage by ROS/RNS, is attributed to a pathway involving PARP (goly4DPR£olymerase) (Kuhn et al., 2005). PARP inhibitors were utilized to inhibit ADPR production
following oxidative stress and prevent or reduce the current o f TRPM2 (Fonfria et al.,
2004; Wilkinson et al., 2008). It was observed that the PARP inhibitors abolished the H 2O2
evoked rises in [Ca2+]i and inhibited cell death (Fonfria et al., 2004). Over expression of
PARP-1 (mediates ADPR production induced by DNA damage) significantly restored
currents in DT40 lymphocyte cells deficient in PARP expression (Buelow et al., 2008;
Kuhn et al., 2005). In summary the ADPR-dependent process involves the production of
ADPR from the nucleus and mitochondria, and results in TRPM2 activation by free ADPR
in the cytosol.
9

An alternative mechanism involves an ADPR-independent process. TRPM2
transfected HEK cells were utilized in a set of experiments whereby H 2O 2 was
administered (Wehage et al., 2002). Wehage et al., (2002) administered H 2O2, which
caused an increase in [Ca2+]i consistent with previous experiments from another group
(Perraud et al., 2005). A splice variant with two deletions in the C-terminus (TRPM2-AC),
were prepared in HL-60 cells and neutrophil granulocytes. Results demonstrated that
administered H 2O2 activated TRPM2-AC, similarly to wild-type TRPM2. However,
recordings with TRPM2-AC did not respond to ADPR, suggesting that oxidative stress via
H 2O2 was sufficient to activate TRPM2 (Perraud et al., 2005). In summary, the role of
TRPM2 channels as sensors of oxidative stress results in a Ca2+ influx evoked by H 2O2
•

1

'

:

/

(ADPR-dependent and independent mechanisms) which may mediates cell death
(Naziroglu and Luckhoff, 2008b).
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Figure 2: Intracellular ADPR production. The first source of intracellular ADPR
production is through the mitochondria ( 1), and the second source is from DNA repair
enzymes, PARG (polyADPR-glycohydrolase) and PARP (polyADPR-polymerase) (2).
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Pharmacology o f TRPM2:
There are no specific inhibitors o f TRPM2. However adenosine monophosphate
(AMP) has been demonstrated to reduce TRPM2 activation by binding to the NUDT9-H
domain, thereby preventing ADPR binding (Grubisha et al., 2006). In addition, 8-BrcADPR has been shown to decrease TRPM2 channel activation caused by ligands
including, cADPR and NAD+ (Beck et al., 2006; Kolisek et al., 2005; Lange et al., 2008;
Togashi et al., 2006).
The following pharmalogical agents have been reported to inhibit TRPM2 channels;
flufenamic acid (FFA), imidazol anti-fungal agents (clotrimazole and econazole), N-(pamylcinnamoyl) anthranilic acid (ACA), and 2-aminoethoxydiphenyl borate (2-APB) (Hill
et al., 2004a; Hill et al., 2004b; Jiang et al., 2010; Togashi et al., 2006). However none of
the inhibitors are TRPM2 selective and may inhibit a wide variety o f ion channels.
Due to PARPs involvement with TRPM2 activation, PARP inhibitors were tested
by various groups as a means o f reducing TRPM2 activation. The PARP family contains
approximately 18 proteins (Ame et al., 2004; Eisfeld and Luckhoff, 2007); however the
focus o f most research is on poly(ADPR) polymerase-1 (PARP-1), since PARP-1 is
involved in the pathway that produces ADPR from the nucleus or mitochondria (Eisfeld
and Luckhoff, 2007; Kuhn et al., 2005). Various PARP inhibitors have been demonstrated
to reduce or block the increase in [Ca2+]i induced by H 2O2 including: PJ34, DPQ,
SB750139-B and ABT-888 (Donawho et al., 2007; Fonfria et al., 2004; Kuhn et al., 2005;
Yang et al., 2006). A caveat that arises with these PARP inhibitors is that the
concentrations required to block H202-induced TRPM2 activation is much greater than
those required in-vitro (Eisfeld and Luckhoff, 2007; Scharenberg, 2005). In addition, the
12

concentrations required for inhibition varies greatly amongst PARP inhibitors. To
determine if PARP inhibitors directly interacted with TRPM2, Fonria et al., (2004)
performed experiments with PARP inhibitors in the presence or absence of ADPR in the
ICS. Activation o f TRPM2 currents was observed under both conditions suggesting that
inhibitors do not interfere with TRPM2 directly but rather act by limiting ADPR
production (Fonfria et al., 2004). There is evidence that PARP inhibitors are involved with
blocking TRPM2 activity induced by oxidative stress; however more extensive research
will be required to determine the mechanism and efficacy of these inhibitors.
Lanthanum (La3+) and gadolinium (Ga3+) ions are non-specific channel blockers
known to inhibit TRP channels (Hardie, 2003; Minke, 2010). More specifically, two
channels within the TRPM family are susceptible to inhibition by La

and Ga , namely

TRPM3 and TRPM7 (Harteneck, 2005). In contrast, TRPM2 was demonstrated to be
insensitive to inhibition by La3+ and Ga3+ (Harteneck, 2005).
1.5 Ca2+ and TRPM2 function
Experiments performed by Perraud et al., (2001) suggested the possibility that Ca
may facilitate TRPM2 activation by ADPR. (Perraud et al., 2001). In these experiments
they varied the intracellular Ca

concentration ([Ca

demonstrated that elevating intracellular Ca

]¡) during their recordings and

potentiated the development and peak

amplitude o f ADPR-evoked TRPM2 currents, (Perraud et al., 2001).This further suggested
a synergistic effect of intracellular Ca

and ADPR on TRPM2 activation. Interestingly,

subsequent studies demonstrated that TRPM2 channel function was also dependent on
extracellular Ca2+ (Hara et al., 2002).This dependence was serendipitously observed while
conducting ion substitution experiments. Indeed currents were abolished when extracellular
13

Ca2+ was omitted from the extracellular solution (ECS) (Csanady and Torocsik, 2009; Hara
et al., 2002; McHugh et al., 2003; Starkus et al., 2007). Similarly, McHugh et al., (2003)
A

substituted equimolar concentrations of Ba

i

■

for Ca which resulted in a rapid inhibition of

TRPM2 channel currents (McHugh et al., 2003). This demonstrated that Ca2+-free ECS
could be administered during whole-cell recordings to turn the channel off. This suggested
that the presence o f intracellular Ca

was necessary for channel activation through Ca

influx (Starkus et al., 2007). The mechanism underlying this Ca2+-dependence remained
unknown until a consensus IQ-like m otif for calmodulin (CaM) binding was identified
within the N-terminus o f TRPM2. This m otif was shown to play an essential role with
A

I

respect to channel regulation via intracellular Ca -CaM (McHugh et al., 2003; Starkus et
al., 2007). This was demonstrated by showing Ca2+ influx enhanced the interaction o f CaM
and Ca2+ with TRPM2 at the IQ-like motif (Tong et al., 2006).
1.6 Calmodulin
Calmodulin is a ubiquitously expressed Ca

binding protein, containing four EF-

hand motifs, each o f which can bind Ca2+. Ca2+ binding to these EF hands promotes a
conformational change within the complex allowing CaM to interact with other proteins
I

(Gordon-Shaag et al., 2008; Togashi et al., 2006). CaM is well known to serve as a Ca
. . .
«,
sensor for various ion channels (voltage- and ligand-gated) that are regulated by Ca
(Saimi and Kung, 2002). For example, CaM has also been demonstrated to be involved
with Ca -dependent activation observed in many types of voltage-gated calcium channels
(VGCCs) (McHugh et al., 2003; Wykes et al., 2007; Xia et al., 1998). L-type calcium
channels are amongst one type o f voltage-gated calcium channels that demonstrate Ca2+dependent activation which involves CaM (Imredy and Yue, 1994; Zuhlke et al., 1999;
14

Zuhlke et al., 2000; Zuhlke and Reuter, 1998). As noted in the preceding section, the
regulation o f TRPM2 channels by Ca2+ depends on the interaction between intracellular
Ca2+ and CaM (Ca2+-CaM). Although it has been observed that extracellular Ca2+ causes
A ,

activation, there is little evidence to suggest that it is due to the action of Ca at an external
regulatory site. McHugh et al., (2003) buffered free [Ca2+]i to 100 nM using BAPTA (2bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) to determine if the effect o f Ca
occurred at an intracellular or extracellular site (McHugh et al., 2003). The reduction in the
A I

effect o f extracellular Ca

^

I

on currents using BAPTA, demonstrated that the effect of Ca

was not at an extracellular site. Instead, Ca2+ binding from an intracellular domain within
TRPM2 channels appeared to be critical for activation (McHugh et al., 2003).
Starkus et al., (2007) administered a known CaM antagonist, calmidazolium, to
determine the role o f CaM with respect to activation of TRPM2 channels (Starkus et al.,
2007). In the presence o f calmidazolium activation of TRPM2 was significantly reduced
suggesting that CaM contributed to TRPM2 activation (Starkus et al., 2007). Experiments
using CaM mutants incapable of binding Ca2+, provided further evidence for a role of CaM.
The CaM mutants were prepared by aspartic acid substitutions in all four Ca

2+V
binding sites

on the EF hand motifs o f CaM (Tong et al., 2006). Coexpression of CaM and CaM mutants
resulted in a decrease in the activation o f TRPM2 currents measured by the rate o f rise and
the peak amplitude o f the current (Tong et al., 2006). These results indicated that CaM is
the Ca2+ sensor responsible for activation o f TRPM2, and also demonstrated that mutated
CaM competed with endogenous CaM for binding. Since half of CaM is associated with
the

plasma membrane

and the

rest

is

free

in

the

cytoplasm

and

nucleus,

coimmunoprecipitation was performed by Tong, Q et al., (2006) to determine how CaM
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interacts with TRPM2. It was determined that CaM directly interacts with TRPM2 at both
N and the C termini, however higher affinity CaM binding at a site residing within the N
terminus was observed (Tong et al., 2006). The sequence on the N terminus is defined as a
IQ-type consensus m otif which is situated between amino acids 406-416 (Tong et al.,
2006). The importance o f this sequence was determined using site-directed mtutagenesis
experiments. It was demonstrated that mutations to only two amino acids within the IQm otif resulted in significant reduction in CaM binding. However, binding of CaM was still
observed in TRPM2(IQ-mutants) suggesting that CaM may bind to other regions of
TRPM2.
1.7 Ca2+-dependent inactivation
In addition to regulating Ca2+-dependent activation, CaM plays a vital role with
Ca2+-dependent inactivation described in L-type calcium channels. Inactivation is
important to maintaining physiological levels of Ca , acting as a negative feedback
mechanism. It has been demonstrated that the binding of Ca

to the long cytoplasmic, C-

terminal tail of the aic subunits in L-type calcium channels is responsible for the observed
Ca2+ dependent inactivation (Zuhlke et al., 2000; Zuhlke and Reuter, 1998). However the
location o f the Ca2+binding site on the C-terminal tail has been debated. Experiments with
deletions o f the first 8 amino acids o f the IQ-motif in the C-terminal tail of the aic subunit
resulted in abolishment of Ca2+-dependent inactivation (Zuhlke and Reuter, 1998). This
provided evidence for Ca2+-dependent inactivation of L-type calcium channels, but little is
known about the interaction with CaM. A CaM mutant was prepared to test the
involvement o f CaM with respect to Ca2+-dependent inactivation. The CaM mutant
consisted o f an aspartate substitution for alanine in three o f four o f the Ca -binding EF16

hand motifs (Xia et al., 1998). Expression of the CaM mutant inhibited Ca2+-dependent
inactivation o f L-type calcium channels. This suggests that CaM plays a crucial role in the
Ca2+-dependent inactivation o f L-type calcium channels. The role of CaM with regards to
Ca2+-dependent activation and inactivation make L-type channels unique. Another example
o f Ca2+-dependent inactivation is present in NMDA (ion-channel), whereby it is regulated
by the binding o f Ca2+-CaM with the NR1 subunit o f NMDA (Lu et al., 2000; Zhang et al.,
1998). The administration of CaM to the intracellular solution resulted in an increase in the
Ca2+ dependent inactivation o f the currents (Lu et al., 2000; Xia et al., 1998). In summary
the interaction of Ca2+-CaM has been demonstrated to be essential to Ca2+-dependent
regulation (activation or inactivation, or both) in various Ca
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channels.

•

Figure 3:

"**

•

Schematic of TRPM2 illustrating C a2+-CaM dependent regulation.

Localized in the N terminal tail of the channel is an IQ-type CaM binding motif (amino
acids 406-416) a site of Ca2+-CaM interaction.
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•

1.8 Hypothesis and objectives
Activation o f TRPM2 channels has been well characterized (Tong et al., 2006);
however, inactivation of TRPM2 channels remains poorly understood.

In preliminary

recordings we observed a time-dependent inactivation process evident in voltage-clamped
recordings from HEK 293 cells stably expressing TRPM2. The tight regulation of
intracellular Ca2+ is critical for maintaining physiologically ideal Ca2+ concentrations
within the cell, important for proper function of cells. Ca2+- and CaM- dependent feedback
regulation represents a recurring theme among Ca

permeable channels (voltage- and

ligand-gated) (Saimi and Kung, 2002). Therefore, we hypothesize that the interaction of
Ca2+ and CaM with TRPM2 plays a role in the inactivation o f TRPM2 channels.
With the following specific research objectives in mindT"'experiments were
performed to characterize the Ca2+-dependent inactivation observed in TRPM2 as follows:
1) To determine the ADPR concentration-dependence o f TRPM2 inactivation
and recovery.
2) To determine the dependence o f inactivation on voltage.
3) To determine the dependence o f inactivation on extracellular Ca .
4) To determine the dependence of inactivation on intracellular Ca .
5) To determine whether CaM regulates inactivation.
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Section 2
Methods and Materials
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2.1 Whole-cell recordings from HEK 293 cells
HEK 293 cells stably expressing TRPM2 were provided by Dr. A. M. Sharenberg
(University o f Washington and Children’s Hospital and Medical Center, Seattle,
Washington). These cells contained a flag-tagged TRPM2 construct which is inducible
(Perraud et al., 2001). Cells were cultured at 37°C with 5% CO2 in Dulbecco’s Modified
Eagle

Medium

(Sigma).

Media

contained

10%

fetal bovine

serum

and

1%

penicillin/streptomycin (Invitrogen). Doxycycline (lp g m l'1) was administered to cells 1224 hours before experiments.
HEK 293 cells stably expressing TRPM2 were held at -60 mV during whole-cell
voltage-clamp recordings (unless otherwise indicated), performed utilizing Axopatch-IB
amplifier (Molecular Devices, Sunnyvale, CA). Currents were evoked through the
intracellular application o f ADPR (0.1-1 mM). Extracellular solutions containing various
Ca2+ concentrations were applied using a multi-barreled fast perfusion system (Figure 4).
The intracellular solution (ICS) contained (in mM): 130 CsGluconate, 10 HEPES, 2
MgCk, 1 CaCk, 0.1-1 ADPR, 20 EGTA (ethylene glycol tetraacetic acid), pH 7.3 (adjusted
\

with CsOH) and osmolarity between 295 and 300 mOsm. The final resistance of ICS-filled
electrodes was between 3 and 5 MG. The standard extracellular solution (ECS) was
composed o f (in mM): 140 NaCl, 5.4 KC1, 25 HEPES, 33 glucose, 1 MgCl2, pH of 7.4
(adjusted with NaOH) and osmolarity between 310 and 315 mOsm. ECS containing Ca2+
was prepared with 2mM CaCl2. When omitting extracellular Ca2+ from the ECS (Ca2+-free
ECS), equimolar substitution with BaCl2 (2mM) was employed in order to maintain a
constant extracellular osmolarity and total divalent concentrations. All data collected was
filtered at 2kHz, digitized and acquired utilizing pClamp (Molecular Devices).
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Figure 4: Schematic of whole cell recording from HEK 293 cells stably expressing
TRPM 2. (A) Illustration of the multi-barreled fast perfusion system used during whole
cell recordings to administer various solutions. (B) HEK 293 cells stably expressing
TRPM2 viewed under phase constrast (Lidia Brandes).
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2.2 Single-point mutation protocol for calmodulin mutants
CaM l sequence was first cloned from a human cDNA library by PCR cloning.
Note, this sequence has 100% homology at the amino acid level to the mouse sequence.
The resulting PCR product, from CaMl primers, was run on a 1.2% agarose gel. The
CaM l band was cut out and the DNA was extracted. The CaMl DNA was digested with
AscI and Notl for 2 hours at 37°C and ligated to pCDNA3.1 and pIRESpuro-Flag plasmids.
Transformed JM109 bacteria with the ligation mix and plated on LB-Amp agar plates
overnight at 37C. The colonies were picked and plasmid DNA extracted. Plasmids were
analyzed by restriction digest with AscI and Noth The positive plasmid was sequenced and
confirmed.

^

Three functional dominant negative CaM l mutants were prepared by single point
mutations at the EF hands on either the N-terminus or C-terminus of CaM l. The four EF
hands correspond to amino acids 21, 57, 94 and 130. CaMi^ mutant was prepared by
substituting aspartate (D) for alanine (A) at amino acid 21 and 57 (EF hands 1 and 2 in
Figure 5A). CaM3>4 mutant was prepared by substituting aspartate (D) for alanine (A) at
amino acid 94 and 130 (EF hands 3 and 4 in Figure 5A). Lastly, CaMij2,3,4 mutant was
prepared by substituting aspartate (D) for alanine (A) at all four EF hands.
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Figure 5: Calmodulin mutant. (A) Schematic of Calmodulin. Three Calmodulin mutants
were prepared with single point mutations at the EF hands illustrated by the red filled
circles. (B) HEK 293 cells stably expressing TRPM2 with transfected functional dominant
negative CaM mutants, in comparison to (C) the same cells under fluorescence indicating
cells expressing GFP and the desired DNA.
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2.3 Lipofectamine 2000 transfection for HEK 293 cells
Cells were plated onto 35 mm dishes and maintained until reaching 90% confluence
before transfection with Lipofectamine 2000. Cells were incubated with 1ml Opti-MEM
per 35 mm plate for at least 1 hour prior to transfection. For each transfection sample,
complexes were prepared as follows:
a. Tube 1 contained: 10 pg DNA (7.5 pg pCDNA 3.1 CaM mutants and 2.5 pg
GFP-pCDNA 3) and 1250 pi Opti-MEM. GFP tagging was implemented to
fluorescently visualize the presence o f the CaM mutant DNA. DNA was diluted
in Opti-MEM Reduced Serum Medium without serum and mixed gently.
b. Tube 2 contained: 12.5 pi Lipofectamine 2000 and 1250 pi Opti-MEM.
Lipofectamine 2000 was gently mixed before use and then diluted to the
appropriate amount in Opti-MEM Medium. The complex was incubated for 5
minutes at room temperature. Note: Proceeded to step c within 25 minutes.
c. After the 5 minute incubation, the diluted DNA was combined with diluted
Lipofectamine 2000 (tube 1 and 2). This was mixed gently and incubated for 20
\

minutes at room temperature. Note: Complexes are stable for 6 hours at room
temperature.

The resulting DNA: lipofectamine complexes were added to each cultured dish with
medium and mixed gently (total volume = 5 ml per 100 ml plate or 1 ml per 35 mm plate).
Cells were incubated cells at 37°C in a CO 2 incubator for 18-24 hours prior to testing for
transgene expression. Media changed after 4-6 hours.
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2.4 Chemicals, drugs, and peptides
The sources o f the following chemicals and drugs are as listed: CaCl2, MgCl2,
BaCl2, Gluconic acid, CsOH, ADPR, Mg(ATP)2, BAPTA, EGTA, W7 and Calmodulin
(Sigma), Calmodulin Inhibitor Peptide (Calbiochem), and HEPES (BioShop).

2.5 Data analysis/stats
All population data are expressed as mean +/- standard error. Paired t-test was used to
compare within groups, Students t-test was used to compare between two groups, and the
ANOVA test was used to analyze multiple groups. The time constant o f recovery (x) was
determined from exponential decay fits (y+AeA(-x/x)) applied to plots of P2/P1 versus
time (sec).
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Section 3
Results

3.1 Time-dependent inactivation of TRPM2 channels in HEK 293 cells
Administration o f extracellular Ca2+, in the presence of intracellularly applied
ADPR, results in TRPM2 channel activation; the resulting currents are abolished upon
removal o f extracellular Ca2+. Thus, with ADPR added to the ICS, channel activation can
r\ «

be controlled by varying extracellular Ca , as shown in Figure 6. The ability of
extracellular Ca2+ removal to abolish TRPM2 current has been previously described
(Csanady and Torocsik, 2009; Hara et al., 2002; McHugh et al., 2003; Starkus et al., 2007).
During recordings with HEK 293 cells stably expressing TRPM2, I observed a timedependent progressive

decrease in TRPM2

current amplitude during prolonged

extracellular Ca2+ (2 mM [Ca2+]) applications (Figure 6). In these experiments, the protocol
for recording was as follows; whole-access was achieved in the presence o f extracellular
Ca2+ with ADPR added to the ICS. Under these conditions, the initial rate of current onset
is limited by the diffusion rate of ADPR from the patch pipette to the cell interior. Currents
Q t

were allowed to reach approximately 1 nA following which extracellular Ca

was

I

removed and cells were continuously maintained in Ca -free solutions for 3 minutes. This
\

allowed sufficient time for ADPR to equilibrate with the cell interior and ensured that
maximum currents amplitude would rapidly be reached upon re-application of extracellular
Ca2+. The currents in whole cell recordings from HEK 293 cells stably expressing TRPM2
were observed to reach a peak within a few minutes, then decay to a steady state in the
continued presence o f extracellular Ca2+ (Figure 6). This gradual decline in current
amplitude in the continued presence o f Ca2+ is referred to as inactivation. We reasoned that
if inactivation is a Ca2+ dependent process, channels should progressively recover from
inactivation following a time period in Ca2+-free ECS. With 0.3 or 1 mM ADPR added to
28

the .ICS, I systematically varied the duration o f Ca2+-free ECS between successive Ca2+
ECS applications allowing us to determine the time course o f recovery following
inactivation. Four time sessions were performed, 10 seconds, 30 seconds, 1 minute and 3
minutes o f Ca2+ free solution (Figures 7 and 8). The ratio of the peak currents generated by
consecutive Ca2+ applications (P2/P1 Ratio) was used as an inactivation index. The time
constant o f recovery (x) for each recording condition (0.3 and 1 mM ADPR; n=4-9 and
n=4-7) was determined from exponential fits applied to plots o f P2/P1 versus time (sec)
(Figure 9).
The following recordings were performed by varying the time interval of Ca2+-free
solution administration to determine the extent o f inactivation in the presence o f Ca .1
observed a significant reduction in peak following inactivation in recordings with 10 sec of
Ca2+-free solution administration (Figure 7A )., However, administration of Ca2+-free
solution for 3 minutes resulted in a subsequent recovery o f the second peak (Figure 7B).
With evidence that TRPM2 has a time course o f recovery following inactivation, we then
determined whether time course of recovery from inactivation was dependent upon the
concentration o f ADPR. Two concentrations o f 0.3 mM and 1 mM were utilized (Figures 8
and 9). A peak-to-peak analysis was performed to determine the extent of recovery
following inactivation. The analysis of the time constant of recovery indicated that the time
required for TRPM2 to fully recover from inactivation was dependent on the concentration
o f ADPR.

In the presence of 0.3 mM ADPR, the time constant for recovery was 23

seconds, whereas in the presence o f 1 mM ADPR, the time constant increased to 43
seconds (Figure 9).
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Ca 2*

OCa2*

0 Ca 2+

Figure 6: Tim e-dependent inactivation in H E K cells stably expressing TRPM 2. Large
inward current recorded from a single HEK 293 cell stably expressing TRPM2 with the
addition o f 0.3 mM ADPR to the intracellular slution (ICS) showing the progressive
inactivation in the presence o f 2 mM extracellular Ca2+ (3 minutes o f Ca2+ ECS
application).

0 C a 2+

B

Figure 7: Time course of recovery w ith varying times of Ca2+ free solution
adm inistration. (A) 10 seconds o f Ca2+-free solution administration. (B) 3 minutes of
Ca2+-free solution administration. Illustrating the recovery of 2nd peaks in comparison to
the 1st peaks.
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Figure 8: Recovery from inactivation w ith varying ADPR concentration. (A)-(B)
Representative recordings from 4 different HEK 293 cells stably transfected with TRPM2.
Recovery from inactivation was assessed by varying the duration of Ca2+-ffee solution
applied between successive Ca

applications. The ratio of the peak currents generated by

consecutive Ca2+ applications (P2/P1 Ratio) was used as an inactivation index. As can be
seen by comparing traces in (A) and (B); high ADPR (1 mM) slowed the recovery from
i

inactivation at both Ca -free time intervals shown (10 and 30 sec).
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Time (sec)

Figure 9: Time course of recovery from inactivation is dependent on the concentration
of ADPR. The time constant of recovery (x) under each recording condition (0.3 and 1 mM
ADPR; n=4-9 and n=4-7) was determined from exponential fits applied to plots of P2/P1
versus time (sec) of Ca2+-free solution administration.
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3.2 Inactivation as a Ca2+-dependent process
In previous recordings, cells were voltage-clamped at -60 mV. To determine the
dependence o f inactivation on membrane potential, experiments were performed in which
the holding potential was varied from -20 to -100 mV. Figure 10A illustrates that as the
membrane is depolarized, the Iss/Ip (steady state to peak ratio) increases reflecting a
decrease in inactivation. This is clearly evident when comparing currents recorded at -100
mV with those recorded at -20 mV. As the membrane becomes more depolarized there is
less driving force for the influx of extracellular Ca

resulting in reduced inactivation

(measured by Iss/Ip) (Figure 10). This supports the role of Ca

influx to the inactivation-

dependent process o f TRPM2.

3.3 Extracellular Ca2+-dependent
I observed a change in inactivation by varying the membrane potential, suggesting
Ca2+-dependence. To test this more directly, the following experiment was performed by
varying the extracellular Ca2+ concentration from 0.2 mM to 5 mM to determine the
\

consequence on the steady state to peak ratio o f TRPM2 currents. As shown with the
representative traces in Figures 11A and 11B, application o f a relatively low concentration
Ca

(0.5 mM) caused robust channel activation with little inactivation evident. As the

extracellular [Ca2+] increased, inactivation was increased. Figure 11C demonstrates the
relationship between Iss/Ip and extracellular [Ca2+].
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A

Holding Voltage
(mV):
-lOOmV

Ca2*

-60mV

Ca2*

-20m V

Ca2*

the holding voltage during whole cell recording. (A) Recording from a single cell. HEK
293 cells were voltage-clamped at -100 mV at breakthrough. Ca2+ solution was
administered for 3 minutes, followed by Ca -free solution for 3 minutes. The holding
voltage (Vh) was changed towards a more depolarized membrane potential and subsequent
^

Ca

I

A I

solution and Ca -free solution were administered. The extent of inactivation was

determined by the Iss/Ip (steady state to peak ratio). (B) Analysis o f the Iss/Ip with respect
to Vh (-100 mV, standard error (SE) +/- 0.02, n=6; -80 mV, +/- 0.01, n=12; -60 mV, +/0.03, n = 6 ;-40 m V ,+/-0.01, n = 5 ;-20 m V ,+/-0.01, n=l 1).
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A

0 Ca2+

Extracellular[Ca2+]: 05mM

2mM

0 Ca2+

0 Ca2+

5mM

B

Extracellular[Ca2+]:

0 Ca2+

°-5mM

0 Ca2+

1mM

0 Ca2+

2mM

r

Figure 11: E xtracellular [Ca ]-dependent inactivation. (A) and (B) single cell
recordings from HEK cells using 0.3 mM ADPR in the ICS. Extracellular [Ca2+] of 0.5
mM-5 mM was administered throughout recordings to determine the extent of inactivation.
The steady state to peak was analyzed and the resulting relationship can be observed in (C).
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3.4 Dependence of inactivation on intracellular [Ca2+]
To determine the dependence of inactivation on intracellular [Ca2+] BAPTA (2bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, fast Ca

chelator/buffer) was

administered within the ICS at 10 mM.
It is known that increasing intracellular [Ca2+] buffering, by utilizing chelators,
reduces TRPM2 channel activation. However, the effect o f high intracellular [Ca2+]
buffering on inactivation has not been previously examined. I anticipated that buffering
intracellular [Ca' \ would result in a reduction in TRPM2 inactivation, since Ca

is

required in synergy with ADPR for inactivation. The buffers utilized were BAPTA and
EGTA. A computer software (Maxchelator) was utilized to determine the approximate
intracellular free Ca

concentration achieved in our ICS and to ensure this value was

approximately equivalent between the 2 conditions. To determine the approximate free
Ca2+ concentrations in the intracellular solution the concentrations of chelators (BAPTA or
EGTA), total Ca2+ and Mg2+ concentrations, and the pH of the solution was utilized in the
calculations. The administration of 10 mM BAPTA and 20 mM EGTA to the ICS reduced
the intracellular free Ca

concentration to approximately 25 and 15 nM respectively

(Maxchelator). Buffering intracellular Ca2+ (with 10 mM BAPTA in the ICS) resulted in a
significant reduction in the peak currents.

More importantly, it also reduced the

inactivation of TRPM2 in contrast to control recordings with 20 mM EGTA (Figures 12AC). In summary, these results show that inactivation is dependent upon intracellular and
extracellular [Ca2+] and the concentration o f intracellular ADPR.
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Figure 12: Inactivation of TRPM 2 is dependent on intracellular [Ca2+]. (A) Recording
in presence o f 10 mM BAPTA within the ICS, in contrast to (B) which contained control
ICS (20 mM EGTA). (C) Analysis of Iss/Ip for control (n-25) and BAPTA containing ICS
(n=7). (D) Peak amplitude for control

(n=25) and BAPTA containing ICS (n=7).

***P<0.0001.
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3.5 Administration of calmodulin
The previous results indicated the importance of [Ca j j to Ca -dependent
inactivation o f TRPM2. We investigated the mechanism by which [Ca2+]i-mediated
inactivation by testing the possible involvement of calmodulin. CaM is ubiquitously found
and contains four EF hand motifs. Ca2+ binds to these motifs causing a structural
rearrangement of CaM. This results in an increased affinity o f CaM binding to various
proteins (Gordon-Shaag et al., 2008).
It is well known that Ca2+-CaM promote Ca2+-dependent inactivation of Ca2+
permeable channels (e.g. VGCC and NMDARs). Recordings with 100 pM CaM in the ICS
showed an increase in inactivation observed as a decrease in Iss/Ip (Figure 14C). This was
a significant decrease in Iss/Ip (*P<0.05) in comparison to control recordings without CaM.
In addition to a decrease in Iss/Ip, the presence o f CaM results in a slower recovery of the
second peak following inactivation. This is evident in comparing recordings with control
and CaM containing ICS. In control recordings the second peak fully recovered following
A

i

the administration o f 3-5 minutes o f Ca -free solution (Figure 13A). In contrast, the
second peak does not fully recover following the administration of 5 minutes o f Ca -free
solution in the presence o f CaM (Figure 13B). To determine the time period of Ca2+-free
solution which results in a full recovery o f the second peak in the presence o f CaM, I
administered 10 minutes of Ca2+-free solution. The administration o f 10 minutes of Ca2+ffee solution resulted in a full recovery o f the second peak (Figure 14A). The slower
recovery following inactivation provided the rationale for performing the time course of
recovery following inactivation in the presence of CaM.
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Similar to the time course experiment with administered ADPR, I performed a time
course study with 5 time points: 10 seconds, 30 second, 1 minute, 3 minutes, 5 minutes and
10 minutes o f Ca2+-ffee solution. A time course analysis is illustrated in Figure 16. It is
evident that recordings with CaM containing ICS resulted in a slower recovery following
inactivation that took approximately 10 minutes to fully recover.

3.6 Calmodulin inhibitors
CaM inhibitors were utilized to determine the role of CaM with respect to Ca dependent inactivation. Membrane-permeable CaM inhibitor W-7 was administered to ICS
and ECS at 10pM (Figure 15A). There was no significant difference in the Iss/Ip between
W-7 and control recordings. Analysis Iss/Ip for CaM-inhibitory peptide administered to
ICS at lOpM (Figure 15B), yielded a similar result. Although these results illustrated no
significant difference in the Iss/Ip in comparison to the control group, this data is more
difficult to interpret. Difficulties arise due to CaM inhibitors (inhibitory peptide and W-7)
affecting activation. This is evident in Figures 15C and D, whereby the second peak is
reduced. This reduction in the amplitude o f the peak may be due to the inhibitors slowing
the recovery o f the channel following inactivation or an effect on activation. The reduction
in amplitude due to the interaction with CaM inhibitors results in an inaccurate
interpretation of Iss/Ip, since the peak in addition to the steady state is affected.
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Figure 13: Representative recordings used to determ ine the extent of peak recovery
following inactivation. Comparison of the recovery of the 2nd peaks with respect to the
initial peaks following the administration of Ca2+-free solution for a duration of 5 minutes.
(A) Control recording showing a full recovery o f the 2nd peak, (B) recording with lOOpM
calmodulin in ICS demonstrating ; a slower recovery of the 2nd peak following the
I

administration o f Ca -free solution.
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Figure 14: Inactivation of TRPM 2 is dependent on calmodulin. Comparison o f the
duration o f Ca2+-ffee solution administration required for a full recovery of the 2nd peaks
with respect to the initial peaks. Representative recordings also illustrates the extent of
inactivation o f the 2nd peak measured by the Iss/Ip. (A) Recording illustrating a full
recovery o f the 2nd peak following the administartion o f Ca2+-free solution for a duration of
10 minutes in the presence of lOOpM calmodulin in ICS (n=5), (B) control recording
(application of Ca -free solution for 5 minutes). (C) Analysis o f Iss/Ip. *P<0.05.

s

i
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Iss/lp

Figure 15: Determining the effect of calmodulin inhibitors on inactivation. (A)
Analysis o f Iss/lp for the membrane-permeable CaM inhibitor W-7 administered to ICS
and ECS at lOpM, W-7(n=6) and control (n=8). (B) Analysis of Iss/lp for CaM-inhibitory
peptide administered to ICS at lOpM, CaM-inhibitory peptide (n=10) and control (n=12).
(C) Example recording with lOpM W-7 within the ICS and ECS, and (D) 10 mM CaMinhibitory peptide to the ICS.

Figure 16: Time course of recovery from inactivation in the presence of calmodulin.
Analysis of the time constant of recovery (x) in recordings with control ICF (n=4-9) and
100pM calmodulin in ICS (n=4-10) determined by exponential fits applied to plots of
P2/P1 versus time (sec) of Ca -free solution administration.
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3.7 Effect o f CaM mutants on inactivation
To further determine the role CaM plays with inactivation in TRPM2 CaM mutants
were developed. Three functional dominant negative CaMl mutants (Peterson et al., 1999)
were prepared by single point mutations at the EF hands. These mutations took place on
either the N-terminus or C-terminus of CaM l. The four EF hands correspond to amino
acids 21, 57, 94 and 130 on CaM l. CaMi^ mutant was prepared by substituting aspartate
(D) for alanine (A) at EF hands 1 and 2 (Figure 5A). CaM 3,4 mutant was prepared by
substituting aspartate (D) for alanine (A) at EF hands 3 and 4 (Figure 5A). Lastly,
substitutions at all four EF hands resulted with C a M ^ ^ mutant. Lipofectamine 2000
transfection was used to determine whether CaM mutants had an effect on the extent of
inativation observed in TRPM2 currents. A 3:1 desired DNA to GFP was utilized with
Lipofectamine 2000 transfection.
Control recordings utilized HEK 293 cells stably expressing TRPM2. There was no
significant difference in Iss/Ip between recordings under three conditions: control, no
expression o f GFP, and expression o f both GFP and CaM mutants DNA (Figures 17A, B
and C). The use o f CaM 1,2,3,4 and CaM 3,4 was predicted to cause a complete reduction
in Ca2+-dependent inactivation as seen previously in experiements utilizing L-type Ca2+
channels (Peterson et al., 1999).
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0 .2-

Control

NoGFP

CaM 1,2,3,4 Mul

Figure 17: Calmodulin m utants have no effect on TRPM2 inactivation. Determining
the extent of inactivation by utilizing functional dominant negative CaM mutants
transfected into HEK 293 cells staby expressing TRPM2. (A) Analysis of Iss/Ip for Cam
3,4 mutant (n=5), in contrast to control recordings (n=5) and recordings from cells not
expressing GFP (n=5). (B) Analysis of Iss/Ip for Cam 1,2 mutant (n=7), control recordings
(n=3) and cells not expressing GFP (n=3). (C) Analysis of Iss/Ip for Cam 1,2,3,4 mutant
(n=6), control recordings (n=3) and cells not expressing GFP (n=2).
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Section 4
Discussion

4.1 Summary of key findings
This thesis has characterized the properties of an inactivation mechanism
encountered in HEK 293 cells stably expressing TRPM2. Various novel findings have
resulted through this work as summarized below.
Inactivation of TRPM2 is dependent on:
1) the concentration of ADPR (Figure 9)
Q É

2) Ca

influx (Figure 10 illustrates that inactivation was reduced at more

depolarized membrane potentials, consistent with a reduced driving force and
less influx of Ca2+)
3) extracellular [Ca j ; being almost entirely prevented when extracellular Ca
was reduced to 0.2 mM (Figure 11A)
4) intracellular free [Ca2+] (Figure 12)
The application of calmodulin resulted in a significant increase in inactivation. The time
constant o f recovery following inactivation was 241 sec which was significantly slower
than 28 sec observed in control recordings (Figure 16), suggesting the involvement of CaM
with the Ca2+-dependent inactivation o f TRPM2.

4.2 Progressive time-dependent inactivation of TRPM2
Previous recordings from our lab and others, using HEK 293 cells stably expressing
TRPM2, indicated the possibility these channels might be regulated by an inactivation
process.

TRPM2-mediated currents developed rapidly following the intracellular

application o f ADPR. The currents peaked within a few minutes and then decayed to a
n

I

steady state in the continued presence o f extracellular Ca . Perraud, A.L. et al., (2001)
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described TRPM2 regulation with respect to ADPR and Ca2+ (Perraud et a l, 2001). They
performed whole-cell recordings with varying ADPR concentrations in the ICS. In addition
they included 10 mM BAPTA to buffer [Ca2+]i. Recordings with 0.3 and 1 mM ADPR
resulted in a possible time-dependent inactivation (Perraud et al., 2001). Furthermore, they
buffered free [Ca2+]i to 100 nM abolishing inactivation. Taken together, this hinted at a
possible inactivation process which may be linked to [Ca24]. Whole-cell patch clamp
recordings were performed with inducible TRPM2-expressing HEK 293 cells. The
dependence on extracellular Ca

for TRPM2 regulation was an important characteristic

implemented in our recordings. The administration o f Ca2+ containing ECS to ADPR
within the ICS resulted in a robust current. The initial current was permitted to develop to
approximately 1 nA and was then followed by the administration of Ca -free ECS,
completely inhibiting the current. This protocol was utilized to ensure that a maximal peak
current developed before accessing the extent o f inactivation. Application of Ca2+-free ECS
for 3 minutes following breakthrough ensured complete diffusion o f ADPR into each cell.
The re-application o f Ca

containing ECS re-activated the inward currents carried by
V

cations in response to extracellular Ca application.

4.3 ADPR dose-dependent inactivation of TRPM2
The concentration-dependent activation o f TRPM2 by ADPR has been described in
the literature (Jiang et al., 2010; Perraud et al., 2001; Starkus et al., 2007). However, it is
not known whether or not the concentration o f ADPR plays a role in TRPM2 inactivation.
This thesis demonstrates the dependence o f inactivation on [ADPR], Firstly, we performed
experiments on HEK-293 cells stably expressing TRPM2 to ensure that ADPR provided
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the primary gating mechanism (Jiang et al., 2010; Perraud et al., 2001). In the absence of
ADPR in the patch pipette, there was no current in HEK-293 cells stably expressing
TRPM2. This indicated that HEK-293 cells stably expressing TRPM2 required
exogenously administered ADPR. The initial concentration of ADPR utilized by Dr.
Sharenberg’s group was 100 pM. The EC 50 o f ADPR was approximately 130 pM, which is
comparable to the EC 50 o f 10-90 pM for gating o f TRPM2 in HEK-293 cells (Perraud et
a l., 2001).
Experiments in HEK-293 cells stably expressing TRPM2 were replicated with three
varying ADPR concentrations. The administration o f 100 pM ADPR in the ICS resulted in
very slow activation (not shown), similar to previous reports (Perraud et al., 2001).
However, under these conditions I observed a peak that developed which was not seen in
data from Perraud et al., (2001). In addition, a steady state developed in the presence of
extracellular Ca2+ following a peak amplitude in my recordings with 100 pM ADPR. This
apparent inactivation (utilizing 100 pM ADPR in the ICS) was not observed by Perraud et
al., (2001). The inactivation I observed with lower [ADPR] was dependent on ensuring a
\'
peak current developed before accessing inactivation. Others observed similar activation,
and an apparent inactivation with 300 pM and 1 mM ADPR in the ICS (Figures 8A and B)
p
(Perraud et al., 2001). Different concentrations o f ADPR (0.3-1 mM) evoked currents
which peaked followed by decay to a steady state with similar Iss/Ip ratios at both
concentrations (Perraud et al., 2001). Our application protocols allowed us to consistently
measure peak currents, which may approximate the maximum current. In contrast this was
not done by other groups and they did not attempt to measure inactivation (McHugh et al.,
2003; Perraud et al., 2001; Starkus et al., 2007).
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The discrepancies in inactivation between my results and Dr. Sharenberg’s may be
due to the protocol utilized. Dr. Sharenberg’s group performed voltage ramps (increasing
holding voltage linearly throughout a recording) of 50 ms spanning -100 to + 100 mV,
which were delivered from a holding potential of 0 mV at 0.5 Hz over 200-400 seconds. In
contrast, we did not utilize voltage ramps: our recordings were performed with cells held at
-60 mV during whole-cell voltage-clamp recordings. Another difference was the chelators
a

I

used to buffer the free intracellular Ca . We utilized 20 mM EGTA, in contrast to the 10
mM BAPTA that was administered to the ICS by Dr. Sharenberg’s group. EGTA is a Ca2+
chelator that exhibits high selectivity for Ca

(Ellis-Davies and Kaplan, 1994). Similar to

EGTA, BAPTA is highly selective for Ca2+ (highly selective to Ca2+ over Mg2+) and is
used to control the levels o f intracellular and extracellular Ca2+ (Tsien, 1980). However,
differences between BAPTA and EGTA arise due to the extent of selectivity and ability to
buffer Ca2+. Firstly, BAPTA is more selective for Ca2+ than EGTA (Ahluwalia etal., 2001;
Luzio et al., 2007; Tsien, 1980). In addition, at physiological pH BAPTA binds arid
releases Ca2+ approximately 50-400 times faster than EGTA. This is indicative o f a faster
rate o f association and dissociation for Ca

ions (Ahluwalia et al., 2001; Luzio et al.,

2007). This results in a faster rate o f buffering for BAPTA in comparison to EGTA.
>

2+

Therefore our experiments utilized a slower buffer o f Ca , thus transient changes in
intracellular Ca
of Ca

may still develop in the vicinity o f the channel. These transient influxes

result in a robust inactivation observed in my results evident in Figures 8A and B.

This is in contrast to the use o f BAPTA which would sequester the levels of intracellular
Ca

at a rapid rate, thus preventing Ca

ions from having effects on the channel.
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In addition to ADPR being administered to the ICS, extracellular Ca2+ was also
applied to activate TRPM2. Interestingly the removal o f Ca2+ caused a fast closure of the
TRPM2 channels abolishing the developing currents. This inactivity of the channel does
not reverse until the re-application of extracellular Ca2+ solution. These observations are
illustrated in Figures 6 and 7 and are consistent with previous literature (McHugh et al.,
2003; Starkus et al., 2007). In the next series of experiments we varied the duration of
Ca2+-ffee ECS between successive Ca2+ ECS applications. The reasoning o f these
experiments was to determine if inactivation o f TRPM2 is a reversible process. We
predicted that channels should progressively recover from inactivation following various
n

i

time durations o f Ca -free ECS administration. The following sets of recordings were
performed with 0.3 mM ADPR added to the ICS and the time periods were systematically
varied. Figures 7A and B are representative recordings with 10 seconds and 3 minutes of
Ca -free ECS administration. It is apparent in Figure 7A that the analysis of the 2

peak

following re-administration of Ca2+ ECS to the 1st peak results in a significant reduction in
peak currents following the 10 seconds time period of Ca2+-free ECS. By contrast, Figure
7B is a representative recording whereby we varied the time period o f Ca2+-ffee ECS to 3
minutes and this resulted in comparable peak currents between the 2nd peak and 1st peak
(close to 90% recovery measure by P2/P1). In summary, these results indicate that with 0.3
mM ADPR in the ICS, the channel requires close to 3 minutes o f Ca2+-ffee ECS to fully
A t

recover the initial peak current once Ca

ECS is re-administered.

To determine a time constant of recovery following inactivation, we systematically
performed recordings with varying the time period o f Ca2+-ffee ECS utilizing four time
intervals: 10 seconds, 30 seconds, 1 minute and 3 minutes. Ideally each time interval would
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have been tested in the same cell to minimize variability amongst cells. However, the
prolonged recording durations needed could not be achieved experimentally due to the
progressive deterioration o f recording quality following repeated and prolong TRPM2
activations. Therefore, we tested various intervals on different cells. Nevertheless, in 3
stable and long lasting recordings we tested all four time intervals o f Ca2+-ffee ECS
administration. The time course o f recovery from the pooled recordings at various time
intervals was comparable to these 3 recordings with multiple time intervals o f Ca -free
ECS administration. This helped validate our experimental approach. We then varied the
ADPR concentration used in recordings to ImM in order to determine if the recovéry from
inactivation was dependent on ADPR concentration. The ratios of P2/P1 were employed as
an inactivation index. Representative recordings using Ca2+-ffee ECS intervals o f 10
seconds and 30 seconds are illustrated in Figure 8. Recordings with 1 mM ADPR in the
ICS demonstrated a slower recovery of inactivation in comparison to 0.3 mM ADPR
(Figure 8A and B). The time constant of recovery (x) under each recording condition (0.3
and 1 mM ADPR; n=4-9 and n=4-7) was determined from exponential fits applied to plots
o f P2/P1 versus time (sec) (Figure 9). This analysis demonstrated that recovery following
inactivation o f TRPM2 is dependent on ADPR concentration. Indeed, the time constant in
the presence of 0.3 mM ADPR was 23.2 seconds, whereas recovery was slowed to 42.8
seconds in recordings using 1 mM ADPR (Figure 9).

4.4 Extracellular [Ca2+]-dependent inactivation
It has been demonstrated that extracellular Ca

plays an important role in TRPM2

channel function. The removal o f extracellular Ca2+ abolishes the activity o f TRPM2
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channels (Hara et al., 2002). The influx o f extracellular Ca2+ in the presence o f ADPR is
sufficient to maintain activation of the channel (Csanady and Torocsik, 2009; McHugh et
al., 2003; Starkus et al., 2007).
W ith this in mind, I focused my next set of experiments on the role o f extracellular
Ca2+ on inactivation. The apparent inactivation observed in Figures 6 and 7, occurred in
recordings performed with 2 mM extracellular Ca2+. Under these conditions there was a
significant inactivation process observed. To determine the dependence of inactivation on
extracellular Ca2+, we varied the extracellular [Ca2+]. It was evident that as the extracellular
[Ca2+] increased there was an increase in inactivation as measured by a decrease in Iss/Ip
(Figure 11). It is apparent in Figure 11A and B that inactivation is more sensitive to
varying the extracellular [Ca ] than activation. The amplitudes of the currents were
comparable in Figure 11B at all three extracellular [Ca2+]: 0.5 mM, 1 mM and 2 mM.
However, inactivation (measured by Iss/Ip) was significantly different. In Figure 1IB, the
Iss/Ip for the application o f 0.5 mM extracellular [Ca2+] was approximately 1:1 indicating
the absence o f inactivation. In comparison, inactivation was observed with the
administration o f 2 mM extracellular [Ca2+]. Although inactivation was different amongst
the different extracellular [Ca2+], the peak currents (activation) were similar. While
inactivation has not been studied extensively, Dr. Penner’s group briefly experimented with
varying extracellular [Ca2+] and noted that inactivation was not affected (Starkus et al.,
2007). Increasing extracellular [Ca2+] from a nominally divalent free solution (no
exogenous buffers), to 0.2 mM and 1 mM did not alter the extent of current inactivation
(Starkus et al., 2007). However, the peak currents were significantly different increasing
from -0.2 nA to -8 nA from nominally divalent free solution to 1 mM. In contrast to Dr.
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Penner’s group, we observed that inactivation is dependent on extracellular [Ca2+], In
addition, the peak currents did not vary significantly in our recordings! It is important to
note that Dr. Penner’s group administered 1 mM ADPR in the ICS and buffered the ICS
with 10 mM BAPTA. These inconsistencies in peak current can also be attributed to the
voltage ramp protocol utilized during whole-cell recordings by Dr. Penner’s group.
Recordings from Dr. Penner’s group took place immediately after break through, with a
single application o f Ca2+ solution (Starkus et al., 2007). This protocol would make
inactivation more difficult to interpret since the currents may be affected by both activation
and inactivation. In addition, ADPR may have not fully diffused throughout the cell at the
time o f recording. In comparison, my protocol was developed to ensure that TRPM2
currents had fully developed and that ADPR had adequate time to diffuse throughout the
cell before studying the extent of inactivation.
An additional set of experiments were performed by varying the holding voltage
during recordings. The holding voltage was varied from -20 to -100 mV, in -20 mV
intervals. Figure 10A shows that as the membrane is hyperpolarized there is a decrease in
Iss/Ip indicating an increase in inactivation. This is consistent with an increased driving
force o f Ca2+ ions as the membrane is hyperpolarized, which supports the dependence of
inactivation on extracellular [Ca ]. A linear fit was performed utilizing data from varying
holding voltages. Figure 10B illustrates this analysis o f Iss/Ip to the holding voltage and
predicts that there would be an abolishment in inactivation at approximately +50 mV. This
value approximates the reversal potential (Erev) o f Ca2+. The membrane potential at which
an ion has no net charge across the membrane is termed as the Erev. At the Erev there is a
switch in the overall direction o f the ion flow. This predicted value is consistent with
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literature that performed voltage clamp recordings in myocytes from isolated bull-frog
atrium (Campbell et al., 1988). Under the following extracellular solution conditions: 2-5
mM Ca2+ and 0-5 mM Mg2+, the predicted Erev was computed to be +51.5 +1-2.4 (n=7)
(Campbell et al., 1988). As the holding voltage approaches the Erev o f Ca

of

approximately +50 mV (Campbell et al., 1988), the outward and inward rate of ion flow are
the same and inactivation o f TRPM2 channel is abolished. Therefore, experiments in which
the holding voltage and extracellular [Ca24] were varied provide evidence for the
dependence of inactivation on extracellular Ca .

4.5 Intracellular [Ca2+]-dependent inactivation
Intracellular Ca2+ is necessary for TRPM2 channel gating by ADPR. In addition,
the mechanism o f [Ca24]i-mediated TRPM2 activation has been linked to a CaM-binding
domain (Csanady and Torocsik, 2009; Du et al., 2009; Tong et al., 2006). The following
sets o f experiments were performed to determine the role of intracellular Ca2+ in the
inactivation o f TRPM2 channels. Recordings with 300 pM ADPR resulted in a rapid
increase in current which peaked within 10-30 seconds. However, the peak current
developed much slower in recordings from Dr. Sharenberg’s and Dr. Penner’s groups
(Perraud et al., 2001; Starkus et al., 2007). The slower development of the peaks may be
due to the protocols used in recordings. Both groups utilized BAPTA to buffer the
A

intracellular Ca

|

levels. This is in contrast to the recordings we performed with EGTA.

The approximate free [Ca2+]i levels o f both experimental conditions are 20-30 nM, which is
comparable to 15 nM free [Ca2+]¡in our experiments with EGTA buffering (Maxchelator).
Although the levels of free [Ca2+]i are similar in comparison to literature, the use of
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BAPTA (fast-buffer) in the literature results in a fast rate of Ca2+ buffering, reducing the
effect o f Ca2+on the channel (Ahluwalia et al., 2001; Luzio et al., 2007).
Figures 12A and B are representative recordings with the administration of 10 mM
BAPTA and 20 mM EGTA (control) in the ICS. The large reduction in peak current is
clearly evident in Figure 12A. The peak current amplitude (pA) was compared for both
control and BAPTA-containing recordings. There was a significant difference in peak
^

|

current between the two groups. This further supports the importance of intracellular Ca
for TRPM2 channel activation. This finding is in accordance to previous literature where
buffering o f intracellular free [Ca2+] to approximately 20-30 nM was reported to
significantly reduce peak current amplitudes (0.4-0.6 nA) (McHugh et al., 2003; Perraud et
al., 2001; Starkus et al., 2007).
In addition to the significant reduction in peak current with the administration of 10
mM BAPTA, there was little inactivation observed (total abolishment o f inactivation in the
example recording, Figure 12A). Figure 12C represents the analysis o f Iss/Ip for both
control and BAPTA-containing recordings. There was a significant reduction in
V

inactivation observed in the group o f recordings with BAPTA-containing ICS. Dr. Penner’s
and Dr. Scharenberg’s groups have published recordings with an apparent inactivation
process. Recordings from Dr. Penner’s group utilized 10 mM BAPTA to buffer the
intracellular free [Ca2+] to approximately 30 nM (Starkus et al., 2007). Under these
conditions, recordings show that there is an apparent inactivation. Contrary to this finding,
i
I have shown that under similar buffering conditions there is a significant reduction in
inactivation (Figures 12A and C). Dr. Scharenberg’s group showed similar results with an
abolishment o f inactivation under similar buffering conditions (Perraud et al., 2001). The
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contradictory results with respect to inactivation under the buffering conditions described
may result from the differing protocol used. However, the difficulties with this conclusion
arise since both groups utilized voltage ramp protocols. Our results provide strong evidence
for the dependence inactivation on intracellular [Ca2+].

4.6 Calmodulin as the Ca2+ sensor in L-type Ca2+ channel inactivation
The first evidence of a possible mechanism of Ca2+-sensitive inactivation, which
limits Ca2+ channel activity was discovered in Paramecium (Brehm and Eckert, 1978).
Intracellular [Ca2+] was determined to be essential to the inactivation process of voltage
gated calcium channels (Bechem and Pott, 1985a; Brehm and Eckert, 1978; Imredy and
Yue, 1994). Experiments utilizing L-type Ca2+ channels provided an insight on the
mechanism of Ca2+-dependent inactivation (Imredy and Yue, 1994; Zuhlke and Reuter,
1998). The importance o f intracellular [Ca2+] was established with results demonstrating
that Ca2+ chelators reduced inactivation (Bechem and Pott, 1985a; Bechem and Pott,
1985b; Imredy and Yue, 1994; Romanin et al., 1992). The C-terminal tail of the aie
v
fs I

subunits was the region which was first identified to be responsible for Ca

dependent

inactivation in L-type calcium channels (de et al., 1995; Zhou et al., 1997). To determine
the specific location o f Ca2+ binding site on the C-terminal tail, mutation o f sequence
downstream of the EF hands were performed. This sequence was similar to a CaM
consensus IQ motif, IQXXXRGXXXR (Rhoads and Friedberg, 1997; Saimi and Kung,
2002). Mutations o f this IQ-motif in the C-terminal tail prevented CaM binding and also
blocked Ca2+-dependent inactivation (Qin et al., 1999; Zuhlke et al., 1999; Zuhlke et al.,
2000; Zuhlke and Reuter, 1998). The development of CaM mutants determined the role of
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CaM with respect to Ca2+-dependent inactivation. Peterson et al. coexpressed L-type
channels and mutant CaM. These CaM mutants contained selective mutations at either the
N-terminal or C-terminal lobe, or at both o f the lobes thus making mutants that had Ca
binding impairment (Peterson et al., 1999). The overexpression of CaMi^ mutant, which
lacked Ca

binding in the N-terminal lobe o f CaM, did not affect Ca -dependent

inactivation. In contrast, CaM 3,4 mutant, which lacked Ca

binding in the C-terminal lobe

provided a clear abolishment of Ca2+-dependent inactivation (Peterson et al., 1999). These
experiments with dominant negative mutants o f CaM suggested that CaM is the Ca

9+

sensor for inactivation o f L-type calcium channels. In addition, the dominant negative
effect o f the CaM mutant in the presence of endogenous CaM implies that CaM is
constitutively tethered to the channel (Peterson et al., 1999). This is evident, since
endogenous CaM would have mediated inactivation if mutant CaM was not tethered to the
channel. In summary, an increase in intracellular [Ca j results in Ca

binding to the

constitutively tethered CaM. This Ca2+-CaM complex then binds to the IQ-motif causing
Ca -dependent inactivation (Peterson etal., 1999).
\

4.7 Calmodulin as the Ca2+ sensor in TRPM2 regulation
The importance o f extracellular Ca

94 -

to TRPM2 channel regulation suggested a

possible extracellular site of action for Ca2+ (Starkus et al., 2007). However, further
research indicated that the importance of extracellular Ca

to TRPM2 channel regulation

was due to the influx of Ca2+ (Du et al., 2009; McHugh et al., 2003; Starkus et al., 2007;
Tong et al., 2006). The strong dependence on intracellular [Ca ] for TRPM2 regulation
provided two alternative mechanisms involving intracellular Ca
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94-

(McHugh et al., 2003;

Starkus et al., 2007; Tong et al., 2006). The first mechanism involves a direct interaction o f
intracellular Ca

with an EF-hand on the channel. The second mechanism involves the

interaction o f intracellular Ca2+with calmodulin (McHugh et al., 2003; Starkus et al., 2007;
Tong et al., 2006; Zuhlke and Reuter, 1998). Tong et al. (2006) investigated the
n I

involvement o f CaM as a Ca

sensor for activation of TRPM2. Firstly they explored the

role o f CaM by co-expression of either CaM or the CaM dominant negative mutant
(CaMMux). The functional consequences o f the resulting transfections were determined by
Ca2+ imaging of single transfected cells (Tong et al., 2006). The co-expression of CaM in
TRPM2 expressing HEK 293 cells did not significantly affect changes in intracellular
[Ca2+], which suggested endogenous CaM is sufficient to produce maximal activation of
TRPM2 channels (Tong et al., 2006). In contrast the co-expression of CaMMux blocked the
increase in intracellular [Ca2+]. The resulting inhibition of the intracellular [Ca2+] suggests
that CaMMur competes with endogenous CaM for the same TRPM2 binding site (Tong et
al., 2006). A similar mechanism has been demonstrated in L-type Ca
mentioned earlier (Peterson et al., 1999).

channels as

This mechanism involves CaM being

constitutively tethered to a region in the N-terminus of the aic subunit (Peterson et al.,
1999). Ca2+ influx results in an increase in intracellular [Ca2+] and subsequently a stronger
interaction o f Ca2+ with the tethered CaM. This Ca2+-CaM complex interacts with the IQm otif resulting in structural rearrangement which facilitates Ca2+-dependent inactivation
(Peterson et al., 1999; Tong et al., 2006). Although both channels exhibit similar Ca2+-CaM
regulation mechanisms, it is not known whether CaM is constitutively tethered to TRPM2.
They also demonstrated that TRPM2 and either CaM or CaMMUT undergo direct interaction
through co-immunoprecipitation experiments. Secondly Tong et al. (2006) determined that
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CaM associated with TRPM2 through Ca2+-dependent and also Ca2+-independent binding.
This was demonstrated through immunoprécipitation experiments in the presence o f 100
pM Ca

and 5 mM EGTA. To identify regions of interaction, Tong et al. (2006) prepared

constructs consisting o f either the TRPM2 N terminus (TRPM2-N, amino acids 1-730) or C
terminus (TRPM2-C, amino acids 1060-1503) (Tong et al., 2006). They concluded that
there appears to be two CaM binding sites on TRPM2 (Tong et al., 2006). There appears to
be a weak Ca2+-independent binding of CaM to TRPM2 that occurs at the C-terminus. In
contrast, there is a strong Ca -dependent interaction of CaM with the N-terminus of
TRPM2 (Tong et al., 2006). As aforementioned, there are numerous CaM binding domains
that have been described in literature. One in particular is the IQ motif consensus region
(IQXXXRGXXXR) (Rhoads and Friedberg, 1997; Saimi and Kung, 2002). There is a
recognized IQ-like sequence found at amino acids 406-416 (IQDIVRRRQLL) of TRPM2
(Tong et al., 2006). They confirmed that mutation o f two amino acids in the IQ-like motif
was sufficient to cause significant abolishment o f the binding of CaM to this sequence
(Tong et al., 2006). However, even in the presence o f this mutation CaM binding to fullV

length TRPM2 was still observed. In summary, they demonstrated that the IQ-like m otif of
TRPM2 is essential for die binding of CaM and suggested the possibility of more than one
possible CaM binding region. This was the case with L-type Ca
was the essential Ca

channels, whereby CaM

sensor for both Ca -dependent inactivation and activation (Zuhlke
•ji

et al., 1999). The role CaM played with opposing biological effects made L-type- Ca
channels unique. The possibility o f more than one CaM binding site on TRPM2 poses the
n I

question o f whether activation and inactivation are both linked to CaM as the Ca
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sensor.

4.8 Calmodulin confers an increase in inactivation
Starkus et al. (2010), determined that TRPM2 activation approached 6 nA (slow
activation) at a concentration of 10 pM of ADPR which was close to the EC 50 value in the
absence o f exogenous buffers (Hara et al., 2002; Starkus et al., 2010; Zuhlke et al., 1999).
In contrast, administration of 100 pM CaM to the ICS resulted in rapid activation with
maximal currents exceeding 16 nA. The observed increase in the peak currents may be due
to the increased sensitivity o f Ca2+ due to the elevated CaM near the TRPM2 channel
(Starkus et al., 2007). These studies demonstrated that CaM mediated Ca -dependent
activation. Contrary to this, our results suggest that CaM did not have a significant effect
on Ca -dependent activation. This was determined by the lack o f significance between
activation rates amongst recordings containing control ICS and CaM-containing ICS (data
not shown). However we observed a possible Ca -dependent inactivation process involved
with administered CaM which is a novel finding in TRPM2 channels. Figure 13A and B
illustrate representative recordings with 100 pM CaM to the ICS and control ICS
respectively. Recordings with administered CaM in the ICS indicated an increase in
V

inactivation observed as a decrease in Iss/Ip Figure 14C. This was a significant decrease in
Iss/Ip (*P<0.05) in contrast to control recordings without CaM. The decrease is indicative
o f an increase in the extent o f inactivation. In addition, I observed that the 2nd peak took
much longer to recover following the application o f Ca -free ECS in comparison to
recordings with control conditions (Figure 14A and B). Control recordings were performed
with the time period o f Ca2+-free ECS of 3 minutes, which resulted in approximetely 90%
recovery of the P2/P1 (inactivation index) (Figure 14 B and Figure 13A). Furthermore, this
inactivation index was significantly reduced in recordings with 100 pM CaM in the ICS
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(Figure 13B) indicating that TRPM2 channels took longer to recover following inactivation
in the presence o f exogenous CaM. When the time period o f Ca2+-ffee ECS was increased
to 5 minutes, the inactivation index o f the second response increased indicating the 2nd
peak was more comparable to the 1st peak (Figure 14A). This observation provided the
rationale for performing the time course of recovery following inactivation in the presence
o f 100 pM CaM. The ratio o f P2/P1 was utilized as an inactivation index similar to
previous analysis o f the [ADPR]-dependence on inactivation. We systematically performed
recordings varying the time period o f Ca2+-ffee ECS at six time points: 10 seconds 30
seconds, 1 minute, 3 minutes, 5 minutes and 10 minutes. The addition of the 5 and 10
minutes time periods o f Ca2+-free ECS was utilized to ensure full recovery following
inactivation. The time constant o f recovery (t) under each recording condition (0.3 mM
ADPR and 0.3 mM ADPR in the presence o f 100 pM CaM; n=4-9 and n=4-10) was
determined from exponential fits applied to plots of P2/P1 versus time (sec) (Figure 16).
The time constant in the presence of 100 pM CaM (t=241 seconds) suggests that the
recovery following inactivation is significantly slower compared to recordings under
V

control conditions (t=28.3 seconds)(Figure 16). In addition to our results suggesting CaM
increased the extent of inactivation as measured by a decrease in Iss/Ip (Figure 13A), the
significantly larger time constant in the presence of CaM suggests a possible role of CaM
as the Ca2+ sensor in inactivation.

4.9 CaM inhibitors and mutagenesis
To further investigate the role of CaM as a possible Ca2+ sensor in Ca2+-dependent
inactivation we explored the use o f CaM inhibitors. An effect on inhibition would provide
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further evidence for the invovlement of CaM (Armstrong, 1989; Chad and Eckert, 1986).
Two CaM inhibitors (W-7 and CaM inhibitory peptide) were used to determine their
effects on inactivation. Figure 15A represents an analysis of the Iss/Ip in the presence of
membrane-permeable CaM W-7 to ICS and ECS at 10 pM. However, there was no
significant difference in the Iss/Ip between W-7 and control recordings. Figure 15B
illustrates the analysis Iss/Ip for CaM-inhibitory peptide administered to ICS at 10 pM,
which yielded similar results with respect to inactivation measured by the Iss/Ip. On the
other hand, the effect o f both inhibitors on the 2nd peak are clearly observed in Figure 15C
and D. Although W-7 appears to have a larger impact on the 2nd peak, both results suggest
that the interpretation o f this data is difficult to understand. The possibilty o f CaM being
the Ca2+ sensor for both activation and inactivation would suggest that a CaM inhibitor
would affect both processes. The difficulties in interpretation of these experiments stem in
whether the reduction in the amplitude of the 2nd peak is due to slower recovery following
inactivation or an effect o f the inhibitors on activation. Therefore, this reduction in peak
currents makes the analysis o f Iss/Ip difficult to entirely underdstand. In agreement to this
interpretation, the administration of 10 pM calmidazolium did not effect the extent of
inactivation or the peak currents (data not shown). In contrast, Starkus et al. demonstrated
that 2 pM calmidazolium in the ECS strongly inhibited TRPM2 peak currents and
activation (Starkus et al., 2007). However, other research has demonstrated that various
CaM inhibitors had no effect on Ca2+-dependent activation or inactivation. For example,
Xia et al. (1998) performed patch-clamp experiments on small-conductance calciumactivated potassium-channels (SK channels) a subunits. They concluded that the
application o f 10 pM calmidazolium or 10 pM CaM-inhibitory peptide did not affect peak
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currents that developed with 1 pM Ca2+ (Xia et al., 1998). Varying concentrations of
calmidazolium (1-10 pM) exhibited similar results in L-type Ca

channels (hnredy and

Yue, 1994; Victor et al., .1997; Zuhlke and Reuter, 1998). This lack of effect on regulation
may be due to CaM being permanently tethered to the channel, and thus not accessible to
these inhibitors (Peterson et al., 1999; Pitt et al., 2001; Zuhlke and Reuter, 1998).

In

addtion calmodozolium and other CaM inhibitors may have lower affinities for
constititively tethered CaM (Peterson et al., 1999; Zuhlke and Reuter, 1998). The CaM
inhibitor would be expected to inhibit inactivation if CaM acted as a free molecule in the
cytosol, however CaM may indeed be tethered. Constitutively tethered CaM to the channel
is a possibilty for TRPM2, and this mechanism would be similar to the mechanism
demonstrated in L-type calcium channels (Peterson et al., 1999; Pitt et al., 2001; Zuhlke
and Reuter, 1998).
^ I

An alternative set o f experiments to determine the role o f CaM with respect to Ca
dependent inactivation utilized CaM mutagenesis. CaM mutants were prepared by single
point mutations o f the EF hands at either the N-terminal (CaMi>2) or C-terminal lobe
V

(CaM 3,4) or both (CaMi)2)3)4). Figure 17 compares recordings from the three mutants CaMi)2
(n=7), CaM 3,4 (n=5) and CaMi>2(3,4 (n=6). There were no significant differences amongst
the mutants and control groups with respect to Iss/Ip. The expected outcome would have
A |

predicted in an abolishment o f Ca -dependent inactivation with CaM 3,4 and CaMi)2,3,4
(Peterson et al., 1999). The rationale behind the expected results is due to the selectivity of
CaM binding sites. Two sites on CaM (N terminal and C terminal lobes) play different
roles with respect to regulating the channel (Peterson et al., 1999). This selectivity o f CaM
is well described in L-type Ca2+ channels whereby the C-terminal lobe is responsible for
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Ca2+-dependent inactivation and the N-terminal lobe of CaM is responsible for Ca2+I

dependent activation. However, other VGCC’s such as P/Q-type Ca

channels

A I

demonstrated the opposite selectivity (Wykes et al., 2007). Ca

binding to the C-terminal

lobe o f CaM induces Ca -dependent activation and N-terminal lobe of CaM induces Ca dependent inactivation o f P/Q-type Ca2+ channels (Wykes et al., 2007). In summary, the
observed effect on Ca -dependent inactivation utilizing CaM inhibitors indicates that CaM
is accessible to these inhibitors and may be free in the cytosol. Further support for the
possibility o f CaM being free in the cytosol and not being constitutively tethered to the
channel, arose due to the lack o f results with CaM mutants.

4.10 Physiological and pathophysiological roles of TRPM2
Although TRPM2 is expressed predominately in the brain, it has been detected in
many other tissues. Currents from native TRPM2 have been recorded in various cell lines
including a neutrophil cell line (Heiner et al., 2003) and CRI-G1 insulinoma cells (Inamura
et al., 2003). Togashi et al. (2006) demonstrated a synergistic effect of heat on intracellular
cADPR in pancreatic P-cells which resulted in Ca

influx. The subsequent Ca

influx

provides a possible role for cADPR in the activation of TRPM2 at normal body
temperatures, and regulating insulin secretion in pancreas (Jiang et al., 2010; Togashi et al.,
2006).
Another possible physiological role of TRPM2 depends on the production of
reactive oxygen species (ROS). ROS, for example H 2O2, cause ADPR production further
resulting in activation o f TRPM2 channels (Hara et al., 2002; Kuhn et al., 2005; Perraud et
al., 2005). The role o f TRPM2 with endothelial permeability was demonstrated by
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administering H 2O2. This resulted in an increase in [Ca24]¡ through the opening of TRPM2
channels, increasing endothelial permeability (Hecquet et al., 2008; Hecquet and Malik,
2009; Kuhn et al., 2005; Perraud et al., 2005).
In addition, TRPM2 channels play a role in the production of cytokines from
immune cells during inflammation. Inflammation is a biological response which recruits
proteins and inflammatory cells from the bloodstream to initiate healing and repair of the
damaged area (Yamamoto et al., 2008). The inflammatory response is controlled by a
numbers o f processes, including cytokines. Chemotactic cytokines (chemokines) play a
crucial role with respect to bringing inflammatory cells such as neutrophils and monocytes
from the blood to damaged tissues (Jiang et al., 2010; Luster, 1998; Yamamoto et al.,
2008). During inflammation neutrophils produce various antimicrobial agents including
ROS (Yamamoto et al., 2008). One subfamily o f chemokines, CXCL8, has been
demonstrated to be produced by ROS, including H 2O2 (Jiang et al., 2010; Josse et al.,
2001). An increase in [Ca2+]i through extracellular Ca2+ influx results in a production of
certain cytokines, including CXCL8 (Feske et al., 2001; Wilson et al., 1993; Yamamoto et
al., 2008). However, the mechanism was unknown, until Yamamoto et al. (2008),
demonstrated that H202-induced production of CXCL8 from human monocytic cells is
dependent on TRPM2 (Jiang et al., 2010; Yamamoto et al., 2008).
TRPM2 has been associated with various diseases such as Alzheimer’s disease
(AD), Parkinson’s disease (PD), Western Pacific amyotrophic lateral sclerosis (WP-ALS),
ischemic stroke and bipolar disorder (Hermosura et al., 2008; Hermosura and Gamito,
2007; Jiang et al., 2010; Xu et al., 2006; Xu et al., 2009). One of the common
characteristics o f these diseases is oxidative stress, which results in an unregulated rise in
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[Ca2+]i (Bamham et al., 2004). However the mechanisms or pathways in which TRPM2
affects these pathologies are unknown. For example, bipolar disorder (BD) has been linked
to changes in intracellular [Ca2+] which alters homeostasis (Xu et al., 2006). TRPM2
expression has been found in B-lymphoblast cell lines (BLCLs). Interestingly, research has
shown that TRPM2 expression was significantly lower in BLCLs from BD-I with high
basal intracellular Ca2+ levels (Yoon et al., 2001). This in comparison to BD-II patients
with normal basal intracellular levels o f Ca2+ (Yoon et al., 2001). Altered expression o f BD
protein was demonstrated by Yoon et al. (2001), whereby sustained increases in
intracellular [Ca2+] resulted in a reduction in TRPM2 niRNA levels in BLCLs, promoting
short and long isoforms of TRPM2. They also provided evidence for a link between
variation o f TRPM2 and altered intracellular [Ca2+] homeostasis in BD by illustrating a
relationship between TRPM2 gene variant (intron 19 single nucleotide polymorphisms,
(SNPs)) and elevated in intracellular [Ca2+] in BD-I patients (Xu et al., 2006). Additionally,
TRPM2 variants with mutations resulting from a single amino acid substitution
(Asp543Glu) in SNPs in exon 11 were found in BD-I patients (Xu et al., 2006; Xu et al.,
V '

2009). These findings suggest that TRPM2 gene variants increase the risk of BD and
demonstrated the importance of targeting TRPM2 due to its involvement in the
pathophysiology of BD (Xu et al., 2006).
In addition to BD, ALS, and PD have also been implicated with altered intracellular
[Ca2+]. TRPM2 studies were spurred on by a high occurrence o f ALS and PD (two related
neurodegenerative disorders) in three geographical areas. A TRPM2 variant (TRPM2pl018L)
was found in a case study in both ALS and PD in the subset o f Guam (ALS-G and PD-G).
This variant was represented by a missense mutation with a substitution replacing Pro1018
68

for Leu1018 (Hermosura et al., 2008). The substitution may prevent proper functional
formation which is achieved with Pro1018. This would be indicative of the inability to
maintain ion flow and provides evidence for the severely low levels o f both Mg2+ and Ca2+.
Further research by Hermosura et al. determined that this mutation resulted in a channel
that could not sustain Ca2+ influx compared to wild-type TRPM2 channels in the presence
o f H 2O 2 induction. The reduced Ca

flow was caused by the rapid inactivation of TRPM2

channels exhibiting this mutant. Thus the inability of TRPM2 variant (TRPM2pl018L) to
maintain ion influx through its rapid inactivation resulted in effects that give rise to
neurodegenerative diseases.

4.11 Future directions
The work in this thesis has increased our understanding of the mechanism o f Ca dependent TRPM2 channel inactivation. The following future directions include: extending
work on previous experiments, characterizing the binding o f CaM to TRPM2 and
performing subsequent site directed mutagenesis on TRPM2.
To characterize the association of CaM with the N and C-termini of TRPM2, a pull
down assay should be performed. This would replicate experiments performed by Tong et
al. (2006), which suggested separate sites o f binding Ca2+-dependent and Ca2+-independent
binding (Tong et al., 2006). In addition, site directed mutagenesis at either the N or Cterminus should be performed. The TRPM2-N-Terrn-CaMmut and TRPM2-C-TermCaMmut should be unable to bind CaM and testing these mutant channels for the presence
or absence of inactivation would permit determination o f the role of either region to
inactivation. The rationale for using these mutants was due to the findings by Tong et al.
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(2006), which suggested the possibility o f more than one CaM binding site on TRPM2
(Tong et al., 2006). Since the N-terminus is involved with activation of TRPM2, we
hypothesize that inactivation would be abolished by TRPM2-C-Term-CaMmut.

4.12 Significance of this work
We have focused the present experiments upon the characterization of the TRPM2
channel, which is a novel disease candidate due to its involvement with cell death and it’s
o I

implication with various diseases. We have demonstrated that Ca -dependent inactivation
o f TRPM2 is dependent on: ADPR concentration, extracellular Ca

concentration and

intracellular Ca2+ concentration. We have demonstrated the possibility of CaM acting as the
A I

Ca

sensor in both activation and inactivation o f TRPM2. The lack of results yielded from

the CaM mutants suggest that endogenous CaM was acting in the presence o f the mutants,
indicating that further studies on the involvement o f CaM will be required to folly
understand its role in TRPM2 inactivation.
Our results will advance our understanding of the role of TRPM2 inactivation in the
maintainenance of physiological intracellular [Ca2+]. Therefore, understanding TRPM2
inactivation will provide novel insights with the involvement o f Ca

dysrégulation in

neurodegenerative diseases.

«
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